XML 26 R4.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating expenses:    
Research and development $ 3,816,618 $ 2,832,695
General and administrative 2,826,995 2,805,775
Total operating expenses 6,643,613 5,638,470
Loss from operations (6,643,613) (5,638,470)
Other income (expense):    
Change in fair value of warrant liabilities 31,000 (9,000)
Interest income 126,969 328,545
Net loss $ (6,485,644) $ (5,318,925)
Net loss per share, basic and diluted $ (0.14) $ (0.12)
Weighted average number of common shares outstanding 46,084,383 45,465,754